8-K: Actuate Therapeutics Appoints Crowe LLP as New Independent Auditor Following KMJ Corbin & Company LLP Resignation

Actuate Therapeutics has changed its independent auditor from KMJ Corbin & Company LLP to Crowe LLP, effective August 19, 2024.

Summary

• Actuate Therapeutics, Inc. has replaced its independent registered public accounting firm, KMJ Corbin & Company LLP, with Crowe LLP.
• The change was effective August 19, 2024, coinciding with KMJ's resignation.
• KMJ's audit reports for the fiscal years ending December 31, 2023 and 2022 did not contain any adverse opinions, disclaimers, or qualifications, except for an explanatory paragraph indicating substantial doubt about the company's ability to continue as a going concern.
• There were no disagreements between Actuate and KMJ on accounting principles, financial statement disclosures, or auditing procedures.
• A material weakness in internal control over financial reporting related to clinical trial expense accruals was previously reported by the company.
• Actuate did not consult with Crowe prior to their appointment regarding accounting principles or any matters that were the subject of a disagreement or reportable event.

Sentiment

Score: 5

Explanation: The change in auditors is neutral, but the going concern note from the previous auditor and the previously reported material weakness in internal controls are concerning.

Positives

• The transition to a new auditor was smooth with no reported disagreements on accounting or auditing matters.
• KMJ's audit reports did not contain any adverse opinions or disclaimers.

Negatives

• KMJ's audit reports included an explanatory paragraph indicating substantial doubt about the company's ability to continue as a going concern.
• A material weakness in internal control over financial reporting related to clinical trial expenses was previously reported.

Risks

• The company's previously reported material weakness in internal control over financial reporting could indicate potential future issues.
• The going concern note in the previous auditor's report suggests financial instability.

Industry Context

Changes in auditors are not uncommon, but the circumstances surrounding the change, such as the previous auditor's going concern note, can be significant for investors. The appointment of Crowe, a larger firm, may provide more stability and confidence in the company's financial reporting.

Comparison to Industry Standards

• Auditor changes are a normal part of corporate governance, but the circumstances surrounding the change are important.
• The going concern note from the previous auditor is a significant concern and is not typical for companies with strong financial health.
• The appointment of a larger firm like Crowe is often seen as a positive step, as they have more resources and expertise.

Stakeholder Impact

• Shareholders may be concerned about the going concern note from the previous auditor.
• The appointment of a new auditor may provide some reassurance to stakeholders.

Next Steps

• Crowe LLP will conduct the audit for the fiscal year ending December 31, 2024.

Key Dates

Keywords

auditor, accounting, KMJ Corbin & Company LLP, Crowe LLP, financial reporting, internal control, going concern, audit